Number of patents for skyrizi abbvie?

How many patents does AbbVie/Skyrizi have?

DrugPatentWatch.com tracks patent filings and related data for individual drug products. For Skyrizi (risankizumab), the site’s patent pages can be used to count how many patents are listed for the product across relevant jurisdictions and patent families. The most direct way to get the exact number is to check the Skyrizi entry on DrugPatentWatch.com and use the “patents” count shown there.

You can view Skyrizi’s patent information here: https://www.drugpatentwatch.com/patent/Skyrizi

Why the “number of patents” can differ depending on how you count

The number of patents reported for a drug can change based on whether you count:
- Patent families vs. individual country/patent numbers
- Granted patents only vs. also published applications
- Jurisdictions included (US only vs. US+EU+others)
- Active vs. expired patents

That’s why patent-counting sites (like DrugPatentWatch) are the best source for a consistent, repeatable number.

If you meant “US patents only,” which count should you use?

If you’re specifically looking for US patent counts for Skyrizi, you should use the filtered “US” view on the DrugPatentWatch page (or a US-specific table if provided). The total across all countries will usually be higher than a US-only figure.

Can you tell me which exact number you need?

If you tell me which version you want—US only, worldwide, granted-only, or including applications—I can help you interpret the DrugPatentWatch count format so you use the number that matches your purpose.

Sources

1. DrugPatentWatch.com – Skyrizi (risankizumab) patent page